A 2022 study showed that 28.3% of patients receiving ketamine had a billing diagnosis of depression. McLoughlin's group ...

Patients are commonly diagnosed with treatment-resistant depression when they do not improve despite receiving two or more pharmacologic treatments for an adequate dose and duration during the same ...

Treatment with the investigational psychedelic GH001 was linked with significant improvements in TRD that persist for at ...

A comprehensive meta-analysis in depression and mortality, led by the Department of Psychiatry at the School of Clinical ...

Australia’s first psychedelic trial for treatment-resistant depression has uncovered potential markers that could predict ...

A new study shows longer-term use of generic ketamine for severe depression is safe and effective, but researchers say access to the low-cost option remains limited by funding gaps.

(CNN) — Nick Fournie was 24 years old when severe depression upended his life. Fournie had been married to his longtime sweetheart for two years, and had no reason to suspect he had any mental health ...

Moment of Clarity has released a new resource titled “Is Spravato Covered by Insurance?“, now available on their website. The ...

Sign up for CNN’s Stress, But Less newsletter. Our six-part mindfulness guide will inform and inspire you to reduce stress while learning how to harness it. Nick ...